SEC Form D filed by Immunic Inc.

3/4/26 4:07:54 PM ET

$IMUX

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $IMUX alert in real time by email

Form D

FORM D

Notice of Exempt Offering of Securities

UNITED STATES SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C.

OMB APPROVAL

OMB Number: 3235-0076

Estimated Average burden hours per response: 4.0

1. Issuer's Identity

CIK (Filer ID Number)

Previous Name(s)

None

Entity Type

0001280776

Vital Therapies, Inc.

VITAL THERAPIES INC

Corporation

Limited Partnership

Limited Liability Company

General Partnership

Business Trust

Other

Name of Issuer

IMMUNIC, INC.

Jurisdiction of Incorporation/Organization

DELAWARE

Year of Incorporation/Organization

Over Five Years Ago

Within Last Five Years (Specify Year)

Yet to Be Formed

2. Principal Place of Business and Contact Information

Name of Issuer

IMMUNIC, INC.

Street Address 1

Street Address 2

1200 AVENUE OF THE AMERICAS

SUITE 200

City

State/Province/Country

ZIP/Postal Code

Phone No. of Issuer

NEW YORK

UNITED STATES

10036

(332) 255-9818

3. Related Persons

Last Name

First Name

Middle Name

VITT

DANIEL

Street Address 1

Street Address 2

1200 Avenue of the Americas

Suite 200

City

State/Province/Country

ZIP/Postal Code

New York

NEW YORK

10036

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name

First Name

Middle Name

SKERJANEC

SIMONA

Street Address 1

Street Address 2

1200 Avenue of the Americas

Suite 200

City

State/Province/Country

ZIP/Postal Code

NEW YORK

10036

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name

First Name

Middle Name

NASH

DUANE

Street Address 1

Street Address 2

1200 Avenue of the Americas

Suite 200

City

State/Province/Country

ZIP/Postal Code

New York

NEW YORK

10036

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name

First Name

Middle Name

HOWSON

TAMAR

Street Address 1

Street Address 2

1200 Avenue of the Americas

Suite 200

City

State/Province/Country

ZIP/Postal Code

New York

NEW YORK

10036

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name

First Name

Middle Name

NEERMAN

JOERG

Street Address 1

Street Address 2

1200 Avenue of the Americas

Suite 200

City

State/Province/Country

ZIP/Postal Code

New York

NEW YORK

10036

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name

First Name

Middle Name

RUDICK

RICHARD

Street Address 1

Street Address 2

1200 Avenue of the Americas

Suite 200

City

State/Province/Country

ZIP/Postal Code

New York

NEW YORK

10036

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name

First Name

Middle Name

MUEHLER

ANDREAS

Street Address 1

Street Address 2

1200 Avenue of the Americas

Suite 200

City

State/Province/Country

ZIP/Postal Code

New York

NEW YORK

10036

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name

First Name

Middle Name

WALSH

PATRICK

Street Address 1

Street Address 2

1200 Avenue of the Americas

Suite 200

City

State/Province/Country

ZIP/Postal Code

New York

NEW YORK

10036

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name

First Name

Middle Name

NAGEL

THORVALD

Street Address 1

Street Address 2

1200 Avenue of the Americas

Suite 200

City

State/Province/Country

ZIP/Postal Code

New York

NEW YORK

10036

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name

First Name

Middle Name

KOHLHOF

HELLA

Street Address 1

Street Address 2

1200 Avenue of the Americas

Suite 200

City

State/Province/Country

ZIP/Postal Code

New York

NEW YORK

10036

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name

First Name

Middle Name

WHALEY

GLENN

Street Address 1

Street Address 2

1200 Avenue of the Americas

Suite 200

City

State/Province/Country

ZIP/Postal Code

New York

NEW YORK

10036

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name

First Name

Middle Name

SINGH

INDERPAL

Street Address 1

Street Address 2

1200 Avenue of the Americas

Suite 200

City

State/Province/Country

ZIP/Postal Code

New York

NEW YORK

10036

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name

First Name

Middle Name

PHILLIPS

BARCLAY

Street Address 1

Street Address 2

1200 Avenue of the Americas

Suite 200

City

State/Province/Country

ZIP/Postal Code

New York

NEW YORK

10036

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name

First Name

Middle Name

TARDIO

JASON

Street Address 1

Street Address 2

1200 Avenue of the Americas

Suite 200

City

State/Province/Country

ZIP/Postal Code

New York

NEW YORK

10036

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

4. Industry Group

Agriculture

Banking & Financial Services

Commercial Banking

Insurance

Investing

Investment Banking

Pooled Investment Fund

Other Banking & Financial Services

Business Services

Energy

Coal Mining

Electric Utilities

Energy Conservation

Environmental Services

Oil & Gas

Other Energy

Health Care

Biotechnology

Health Insurance

Hospitals & Physicians

Pharmaceuticals

Other Health Care

Manufacturing

Real Estate

Commercial

Construction

REITS & Finance

Residential

Other Real Estate

Retailing

Restaurants

Technology

Computers

Telecommunications

Other Technology

Travel

Airlines & Airports

Lodging & Conventions

Tourism & Travel Services

Other Travel

Other

5. Issuer Size

Revenue Range

Aggregate Net Asset Value Range

No Revenues

No Aggregate Net Asset Value

$1 - $1,000,000

$1 - $5,000,000

$1,000,001 - $5,000,000

$5,000,001 - $25,000,000

$25,000,001 - $50,000,000

$25,000,001 - $100,000,000

$50,000,001 - $100,000,000

Over $100,000,000

Decline to Disclose

Not Applicable

6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)

Rule 504(b)(1) (not (i), (ii)
or (iii))

Rule 506(b)

Rule 504 (b)(1)(i)

Rule 506(c)

Rule 504 (b)(1)(ii)

Securities Act Section 4(a)(5)

Rule 504 (b)(1)(iii)

Investment Company Act Section 3(c)

7. Type of Filing

New Notice

Date of First Sale

2026-02-17

First Sale Yet to Occur

Amendment

8. Duration of Offering

Does the Issuer intend this offering to last more than one year?

Yes

9. Type(s) of Securities Offered (select all that apply)

Pooled Investment Fund Interests

Equity

Tenant-in-Common Securities

Debt

Mineral Property Securities

Option, Warrant or Other Right to Acquire Another Security

Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Other (describe)

10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?

Yes

Clarification of Response (if Necessary)

11. Minimum Investment

Minimum investment accepted from any outside investor

USD

12. Sales Compensation

Recipient

Recipient CRD Number

None

Leerink Partners LLC

000039011

(Associated) Broker or Dealer

None

(Associated) Broker or Dealer CRD Number

None

Street Address 1

Street Address 2

53 STATE STREET

40TH FLOOR

City

State/Province/Country

ZIP/Postal Code

BOSTON

MASSACHUSETTS

02109

State(s) of Solicitation

All States

Foreign/Non-US

CALIFORNIA

COLORADO

CONNECTICUT

DELAWARE

GEORGIA

ILLINOIS

MASSACHUSETTS

NEW YORK

NORTH CAROLINA

TEXAS

Recipient

Recipient CRD Number

None

STIFEL, NICOLAUS & COMPANY, INCORPORATED

000000793

(Associated) Broker or Dealer

None

(Associated) Broker or Dealer CRD Number

None

Street Address 1

Street Address 2

501 NORTH BROADWAY

City

State/Province/Country

ZIP/Postal Code

ST. LOUIS

MISSOURI

63102

State(s) of Solicitation

All States

Foreign/Non-US

CALIFORNIA

COLORADO

CONNECTICUT

DELAWARE

GEORGIA

ILLINOIS

MASSACHUSETTS

NEW YORK

NORTH CAROLINA

TEXAS

Recipient

Recipient CRD Number

None

GUGGENHEIM SECURITIES, LLC

000040638

(Associated) Broker or Dealer

None

(Associated) Broker or Dealer CRD Number

None

Street Address 1

Street Address 2

330 MADISON AVENUE

City

State/Province/Country

ZIP/Postal Code

NEW YORK

10017

State(s) of Solicitation

All States

Foreign/Non-US

CALIFORNIA

COLORADO

CONNECTICUT

DELAWARE

GEORGIA

ILLINOIS

MASSACHUSETTS

NEW YORK

NORTH CAROLINA

TEXAS

Recipient

Recipient CRD Number

None

WILLIAM BLAIR & COMPANY, LLC

000001252

(Associated) Broker or Dealer

None

(Associated) Broker or Dealer CRD Number

None

Street Address 1

Street Address 2

150 NORTH RIVERSIDE PLAZA

City

State/Province/Country

ZIP/Postal Code

CHICAGO

ILLINOIS

60606

State(s) of Solicitation

All States

Foreign/Non-US

CALIFORNIA

COLORADO

CONNECTICUT

DELAWARE

GEORGIA

ILLINOIS

MASSACHUSETTS

NEW YORK

NORTH CAROLINA

TEXAS

Recipient

Recipient CRD Number

None

LIFESCI CAPITAL LLC

000168404

(Associated) Broker or Dealer

None

(Associated) Broker or Dealer CRD Number

None

Street Address 1

Street Address 2

1700 BROADWAY

40TH FLOOR

City

State/Province/Country

ZIP/Postal Code

NEW YORK

10019

State(s) of Solicitation

All States

Foreign/Non-US

CALIFORNIA

COLORADO

CONNECTICUT

DELAWARE

GEORGIA

ILLINOIS

MASSACHUSETTS

NEW YORK

NORTH CAROLINA

TEXAS

Recipient

Recipient CRD Number

None

B. RILEY SECURITIES, INC.

000025027

(Associated) Broker or Dealer

None

(Associated) Broker or Dealer CRD Number

None

Street Address 1

Street Address 2

11100 SANTA MONICA BLVD

SUITE 800

City

State/Province/Country

ZIP/Postal Code

LOS ANGELES

CALIFORNIA

90025

State(s) of Solicitation

All States

Foreign/Non-US

CALIFORNIA

COLORADO

CONNECTICUT

DELAWARE

GEORGIA

ILLINOIS

MASSACHUSETTS

NEW YORK

NORTH CAROLINA

TEXAS

Recipient

Recipient CRD Number

None

BROOKLINE CAPITAL MARKETS, A DIVISION OF ARCADIA SECURITIES, LLC

000044656

(Associated) Broker or Dealer

None

(Associated) Broker or Dealer CRD Number

None

Street Address 1

Street Address 2

1370 AVENUE OF THE AMERICAS

29TH FLOOR

City

State/Province/Country

ZIP/Postal Code

NEW YORK

10019

State(s) of Solicitation

All States

Foreign/Non-US

CALIFORNIA

COLORADO

CONNECTICUT

DELAWARE

GEORGIA

ILLINOIS

MASSACHUSETTS

NEW YORK

NORTH CAROLINA

TEXAS

13. Offering and Sales Amounts

Total Offering Amount

200000000

USD

Indefinite

Total Amount Sold

200000000

USD

Total Remaining to be Sold

USD

Indefinite

Clarification of Response (if Necessary)

14. Investors

Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering

Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:

15. Sales Commissions & Finders’ Fees Expenses

Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.

Sales Commissions

12000000

USD

Estimate

Finders' Fees

USD

Estimate

Clarification of Response (if Necessary)

6% of the aggregate gross proceeds received by the Company (i) upon the issuance of the Warrants at closing and (ii) upon the cash exercise of the Common Warrants.

16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.

USD

Estimate

Clarification of Response (if Necessary)

Signature and Submission

Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.

Terms of Submission

In submitting this notice, each Issuer named above is:

Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, the information furnished to offerees.

Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated officer of the State in which the Issuer maintains its principal place of business and any State in which this notice is filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any Federal or state action, administrative proceeding, or arbitration brought against it in any place subject to the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or indirectly, upon the provisions of: (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place of business or any State in which this notice is filed.

Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Rule 504 or Rule 506 for one of the reasons stated in Rule 504(b)(3) or Rule 506(d).

Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.

For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.

Issuer

Signature

Name of Signer

Title

Date

IMMUNIC, INC.

/s/ Daniel Vitt

Daniel Vitt

Chief Executive Officer

2026-03-03

Get the next $IMUX alert in real time by email

Recent Analyst Ratings for

$IMUX

Date	Price Target	Rating	Analyst
11/7/2025	$3.00	Buy	Roth Capital
9/29/2025	$13.00	Buy	Chardan Capital Markets
3/25/2025		Outperform	William Blair
11/25/2024	$10.00	Buy	H.C. Wainwright
9/9/2024	$5.00	Outperform	Leerink Partners
8/27/2024	$6.00	Buy	B. Riley Securities
10/21/2022	$5.00	Outperform → Mkt Perform	SVB Leerink
9/19/2022	$26.00	Buy	H.C. Wainwright

More analyst ratings

Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.

Terms of Submission

Recent Analyst Ratings for

$IMUX

Date	Price Target	Rating	Analyst
11/7/2025	$3.00	Buy	Roth Capital
9/29/2025	$13.00	Buy	Chardan Capital Markets
3/25/2025		Outperform	William Blair
11/25/2024	$10.00	Buy	H.C. Wainwright
9/9/2024	$5.00	Outperform	Leerink Partners
8/27/2024	$6.00	Buy	B. Riley Securities
10/21/2022	$5.00	Outperform → Mkt Perform	SVB Leerink
9/19/2022	$26.00	Buy	H.C. Wainwright

More analyst ratings

SEC Form D filed by Immunic Inc.

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$IMUX

SEC Form D filed by Immunic Inc.

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$IMUX

$IMUX
Insider Trading

New insider Bvf Partners L P/Il claimed ownership of 7,590,690 shares (SEC Form 3)

SEC Form 3 filed by new insider Nagel Robert Thorvald

SEC Form 4 filed by Chief Financial Officer Whaley Glenn

$IMUX
Press Releases

Immunic to Participate in Investor Conferences in March

Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update

Immunic Announces Closing of Oversubscribed Private Placement Financing

$IMUX
Analyst Ratings

Roth Capital initiated coverage on Immunic with a new price target

Chardan Capital Markets initiated coverage on Immunic with a new price target

William Blair initiated coverage on Immunic

$IMUX
Insider Purchases

Amendment: President and COO Tardio Jason bought $9,884 worth of shares (12,512 units at $0.79) (SEC Form 4)

Amendment: CEO and Director Vitt Daniel bought $11,550 worth of shares (15,000 units at $0.77), increasing direct ownership by 107% to 29,000 units (SEC Form 4)

Executive Chairman Nash Duane bought $16,694 worth of shares (20,000 units at $0.83), increasing direct ownership by 125% to 36,032 units (SEC Form 4)

$IMUX
SEC Filings